FDA Clears J&J’s Ethicon Monarch Robotic System For Urology Procedures
Executive Summary
J&J’s entry into the kidney stone management market will not threaten Boston Scientific’s leadership position in that market in the near-term, according to Wells Fargo analyst Larry Biegelsen.
You may also be interested in...
CMR Signs Deal With J&J To Bring Robots To Europe And South America
CMR Surgical will collaborate with Johnson & Johnson/Ethicon to expand access to its Versius robotic surgery system.
J&J To Split Consumer From Medtech and Pharmaceutical Businesses – Creating Two Companies To Unlock More Value, Growth, Innovation
Johnson & Johnson expects that the new J&J unit will be better positioned to share expertise such as combing medical devices with drugs and continue to innovate.
New Trial Shows BENEFIT Of J&J/Auris’ Monarch Bronchoscopy Platform
New published results demonstrate J&J/Auris’ robotic is safe and effective at diagnosing peripheral pulmonary lesions.